rs104886039
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001360.3(DHCR7):c.292C>T(p.Gln98*) variant causes a stop gained change. The variant allele was found at a frequency of 0.0000143 in 1,612,982 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001360.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DHCR7 | NM_001360.3 | c.292C>T | p.Gln98* | stop_gained | Exon 4 of 9 | ENST00000355527.8 | NP_001351.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152200Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000361 AC: 9AN: 249176Hom.: 0 AF XY: 0.0000223 AC XY: 3AN XY: 134716
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1460782Hom.: 0 Cov.: 30 AF XY: 0.00000826 AC XY: 6AN XY: 726614
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152200Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74346
ClinVar
Submissions by phenotype
Smith-Lemli-Opitz syndrome Pathogenic:6
- -
- -
Variant summary: DHCR7 c.292C>T (p.Gln98X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant was observed with an allele frequency of 3.3e-05 in 274916 control chromosomes (gnomAD and publications). This frequency is not higher than expected for a pathogenic variant in DHCR7 causing Smith-Lemli-Opitz Syndrome (3.3e-05 vs 0.0043), allowing no conclusion about variant significance. The variant, c.292C>T, has been reported in the literature in multiple individuals affected with Smith-Lemli-Opitz Syndrome (Cardoso_2005, Correa-Cerro_2005, Roullet_2012, Witsch-Baumgartner_2005, Lanthaler_2013, Eroglu_2017). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in <10% of normal activity. A ClinVar submission from a clinical diagnostic laboratory (evaluation after 2014) cites the variant as "pathogenic." Based on the evidence outlined above, the variant was classified as pathogenic. -
- -
- -
This sequence change creates a premature translational stop signal (p.Gln98*) in the DHCR7 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DHCR7 are known to be pathogenic (PMID: 9634533, 10677299). This variant is present in population databases (rs104886039, gnomAD 0.009%). This premature translational stop signal has been observed in individual(s) with Smith–Lemli–Opitz syndrome (PMID: 15776424, 15805162, 15979035, 22929031). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 188723). For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:2
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 28166604, 25525159, 15805162, 25405082, 15776424, 15979035, 28349652, 24500076, 21990131, 22929031, 31589614) -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at